Litcius/Paper detail

Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells

Haiyan Xing, Xue Yang, Yingxi Xu, Kejing Tang, Zheng Tian, Zhaoqi Chen, Yu Zhang, Zhenya Xue, Qing Rao, Min Wang, Jianxiang Wang

2021Cytotherapy27 citationsDOI

Topics & Concepts

LymphangiogenesisCancer researchAngiogenesisChimeric antigen receptorVascular endothelial growth factor CVascular endothelial growth factorVascular endothelial growth inhibitorKinase insert domain receptorBiologyMetastasisVascular endothelial growth factor AImmunologyMedicineImmunotherapyInternal medicineCancerImmune systemVEGF receptorsCAR-T cell therapy researchImmunotherapy and Immune ResponsesRenal and related cancers
Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells | Litcius